0001140361-15-012559.txt : 20150318
0001140361-15-012559.hdr.sgml : 20150318
20150318200230
ACCESSION NUMBER: 0001140361-15-012559
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150316
FILED AS OF DATE: 20150318
DATE AS OF CHANGE: 20150318
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 15711418
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
4
1
doc1.xml
FORM 4
X0306
4
2015-03-16
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2015-03-16
2015-03-16
4
S
0
1000
123.477
D
35258
I
Shares held by Bienaime Family Trust
Common Stock
2015-03-17
2015-03-17
4
S
0
1000
124.866
D
34258
I
Shares held by Bienaime Family Trust
Common Stock
254757
D
Trade made pursuant to a 10b5-1 plan executed March 2, 2015.
The price in column 4 is an average weighted price. The price actually received ranged from $121.98 to $124.52. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
The reporting person an his spouse act as trustees for the Bienaime Family Trust
The price in column 4 is an average weighted price. The price actually received ranged from $123.74 to $126.26. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2015-03-18